These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6409129)

  • 21. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
    Jensen KM; Dahl JB
    Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steady-state maternal and fetal plasma concentrations of glyceryl trinitrate (GTN) in the preterm sheep.
    Bustard MA; Farley AE; Bennett BM; Smith GN
    Can J Physiol Pharmacol; 2003 Sep; 81(9):884-9. PubMed ID: 14614525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitroglycerin adsorption to a combination polyvinyl chloride, polyethylene intravenous administration set.
    Schaber DE; Uden DL; McCoy HG
    Drug Intell Clin Pharm; 1985; 19(7-8):572-5. PubMed ID: 3928309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics and bioavailability of nitroglycerin and its metabolites from Transderm-Nitro, Nitrodisc, and Nitro-Dur II systems using a stable-isotope technique.
    Sun JX; Piraino AJ; Morgan JM; Joshi JC; Cipriano A; Chan K; Redalieu E
    J Clin Pharmacol; 1995 Apr; 35(4):390-7. PubMed ID: 7650229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of lipoic acid in prevention of nitroglycerin tolerance.
    Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
    Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biological availability of glycerol trinitrate after sublingual administration].
    Rietbrock N; Herling C; Muck B
    Arzneimittelforschung; 1989 Feb; 39(2):267-9. PubMed ID: 2499342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption of nitroglycerin and isosorbide dinitrate by infusion tubing.
    Bechtold H; Wiegand A; Kleist P
    Methods Find Exp Clin Pharmacol; 1995; 17(6):359-60. PubMed ID: 8642895
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion sets.
    Nix DE; Tharpe WN; Francisco GE
    Am J Hosp Pharm; 1984 Sep; 41(9):1835-7. PubMed ID: 6437222
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous nitroglycerin delivery: dynamics and cost considerations.
    Nix DE; Tharpe WN; Francisco GE
    Hosp Pharm; 1985 Apr; 20(4):230-2. PubMed ID: 10311085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between drugs and intravenous delivery systems.
    Kowaluk EA; Roberts MS; Polack AE
    Am J Hosp Pharm; 1982 Mar; 39(3):460-7. PubMed ID: 7072732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of glyceryl trinitrate and of isosorbide dinitrate during infusion: a literature survey and practical recommendations.
    Remon JP; Bogaert MG
    Acta Clin Belg; 1983; 38(5):338-41. PubMed ID: 6419518
    [No Abstract]   [Full Text] [Related]  

  • 32. Endothelin ETA receptor antagonist did not affect development of tolerance to glyceryl trinitrate in rat.
    Rai A; Bhalla S; Gulati A
    J Pharm Pharmacol; 2004 Feb; 56(2):271-5. PubMed ID: 15005887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of nitroglycerin from intravenous infusion sets.
    Cossum PA; Galbraith AJ; Roberts MS; Boyd GW
    Lancet; 1978 Aug; 2(8085):349-50. PubMed ID: 79713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitroglycerin-patch induced tolerance is associated with reduced ability of nitroglycerin to increase exhaled nitric oxide.
    Agvald P; Hammar L; Gustafsson LE
    Vascul Pharmacol; 2005 Dec; 43(6):449-57. PubMed ID: 16230051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.
    Jensen KM; Mikkelsen S
    Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
    Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
    J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets.
    Baaske DM; Amann AH; Wagenknecht DM; Mooers M; Carter JE; Hoyt HJ; Stoll RG
    Am J Hosp Pharm; 1980 Feb; 37(2):201-5. PubMed ID: 6767400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous nitroglycerin perfusion techniques--clinical implications.
    Hans P; Paris P; Mathot F
    Intensive Care Med; 1982 Mar; 8(2):93-5. PubMed ID: 6804554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems.
    Cossum PA; Roberts MS
    Eur J Clin Pharmacol; 1981 Feb; 19(3):181-5. PubMed ID: 7215415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.